Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]-
- CAS No.
- 1241280-25-0
- Chemical Name:
- Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]-
- Synonyms
- SAE-14;GPR183, 10 mM in DMSO;GPR183 antagonist SAE-14;Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]-;GPR183 antagonist-1,SAE-14,inhibit,SAE 14,SAE14,HL-60,GPR183,Inhibitor,GPR183 antagonist SAE-14,EBI2/GPR183
- CBNumber:
- CB98236002
- Molecular Formula:
- C19H19F3N2O2
- Molecular Weight:
- 364.36
- MDL Number:
- MOL File:
- 1241280-25-0.mol
Boiling point | 560.6±50.0 °C(Predicted) |
---|---|
Density | 1.321±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO : 100 mg/mL (274.45 mM; ultrasonic and warming and heat to 60°C) |
form | Solid |
pka | 13.59±0.70(Predicted) |
color | White to off-white |
Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]- Chemical Properties,Uses,Production
Uses
SAE-14 (compound SAE-14) is a potent, specific GPR183 antagonist with an IC50 value of 28.5 nM, can antagonize 7α, 25-OHC–induced calcium mobilization with IC50 value below 50 nM in HL-60 cells. GPR183 antagonist-1 can reverse allodynia in mice[1].
in vivo
SAE-14 (compound SAE-14) (i.th.; 2.9 μM; once) can reverse nerve injury-induced allodynia in mice[1].
Animal Model: | Male and female ICR mice[1] |
Dosage: | 2.9 μM |
Administration: | intrathecal (i.th.) injections; 2.9 μM; once |
Result: | Reversed CCI-induced mechanical allodynia in a time-dependent manner. |
References
[1] Kathryn Braden, et al. GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic Pain. J Pharmacol Exp Ther. 2020 Nov;375(2):367-375. DOI:10.1124/jpet.120.000105
Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]- Preparation Products And Raw materials
Raw materials
Preparation Products
Benzenepropanamide, 3,4-difluoro-N-[3-fluoro-5-(4-morpholinyl)phenyl]- Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32432 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3135 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354; | support@targetmol.com | United States | 39031 | 58 |
Nantong Hi-Future Biotechnology Co., Ltd | 18051384581 | sales@chemhifuture.com | China | 3210 | 58 |
Hubei wei shi reagent group ltd., company | 027-59102966 18717199209 | 2853877583@qq.com | China | 2539 | 58 |
TargetMol Chemicals Inc. | 4008200310 | marketing@tsbiochem.com | China | 24989 | 58 |
Shanghai Tachizaki Biomedical Research Center | 18014399201 | sales@chemlab-tachizaki.com | China | 2680 | 58 |
Nantong QuanYi Biotechnology Co., Ltd | 0513-66337626 18051384581 | sales@chemhifuture.com | China | 5840 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11973 | 58 |
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd | 025-58851090 17714375163 | 2881759498@qq.com | China | 13011 | 58 |